WHO Updates Safe-Sex Guidelines to Prevent Zika Transmission

The World Health Organization now recommends that people who visit areas with Zika virus transmission abstain from or have only protected sex for eight weeks.

Written byTanya Lewis
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

PIXABAYTravelers returning from areas with Zika virus transmission should abstain from or have only protected sex for at least eight weeks, according to guidelines from the World Health Organization (WHO) released yesterday (May 31). Couples planning to conceive should also wait eight weeks—or six months if the male partner has symptoms of the virus—WHO officials said during a news briefing. Previously, the organization recommended abstinence or protected sex for four weeks following a person’s return from an area where Zika is circulating.

The new guidelines “reflect what we have learned about Zika disease and its complications,” WHO spokesperson Christian Lindmeier told reporters during the briefing (via NBC News).

Although mosquito bites are the main mode of Zika transmission, as of May 19, there had been 12 studies or reports of sexual transmission of the virus, the Agence France-Presse (AFP) reported. During the past eight years, cases of sexual transmission have been reported in 10 countries, including the United States. All of these cases have been traced back to an infected male partner, according to the AFP.

In May, the WHO encouraged athletes attending this summer’s Olympic and Paralympic Games Rio 2016 to use condoms while in Rio and for four weeks after returning home.

The US Centers ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies